Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Reconstituting tirzepatide chart: 10 mg vial The 10 mg vial is the most commonly used size for compounded tirzepatide
Remarkably, one in three individuals achieved a 25% reduction in body weight, equating to a loss of 58 pounds Semaglutide (Wegovy): Wegovy users have experienced significant weight loss as well, with adults averaging a 15% reduction in body weight and a 16.1% decrease in BMI among children aged 12 and older Clinical trial comparisons: SURMOUNT-1 (Zepbound): Participants using the highest dose of Zepbound (15 mg) experienced an average weight loss of 21% after 72 weeks SURMOUNT-2 (Zepbound): In adults with type 2 diabetes, the same high dose led to a 12% weight loss after 72 weeks Wegovy trials: Comparable trials for Wegovy have shown an average weight loss of 15% from the starting weight in adults who are overweight or have obesity Cost considerations: The price of these medications is a factor to consider
Resources Quality & Verification Pipeline 9-stage QC, HPLC, mass spectrometry Reconstitution Calculator free dosing math tool Knowledge Base & FAQ storage, handling, COA reading Full Research Peptide Catalog Research Library cited articles For research use only
This isnt a quick consult and a prescription
A patient who wants to start GLP-1 treatment within the next 24 to 48 hours rather than waiting for a new patient consultation appointment to become available
